Kala Pharmaceuticals Inc. (NASDAQ:KALA) Posts $2.2 Million In Revenue For INVELTYS...

Max - 0

VYNE Therapeutics Inc. (NASDAQ:VYNE) Reports Revenue Of $3.3 Million in Q3...

Max - 0

Spirits Stocks Deserve a Look as Cabin Fever Sets In (SAM,...

Max - 0

Ocular Therapeutix™ (NASDAQ:OCUL) Report Net Revenue Of $5.9 Million In Q3...

Max - 0

Acadia Pharmaceuticals (NASDAQ:ACAD) Reports NUPLZID® Net Sales Of $120.6 Million In...

Max - 0

Arbutus Biopharma Corporation (NASDAQ:ABUS) Announces Q3 2020 Results and Updates On...

Max - 0

Spectrum Therapeutics Inc. (NASDAQ:SPPI) Announced Q3 2020 Results And Poziotinib and...

Max - 0

Global Blood Therapeutics Inc. (NASDAQ:GBT) Reports $36.9 Million In Net Sales...

Max - 0

Kadmon Holding Inc. (NASDAQ:KDMN) Announce Q3 2020 Results Ahead Of Commercial...

Max - 0

Halozyme Therapeutics Inc. (NASDAQ:HALO) Reports Strong Q3 With Revenue Of $65.3...

Max - 0
1...164165166...248Page 165 of 248